SCHEMBL904088

SCHEMBL904088

CN(CC(=O)OCc1ccc(F)cc1-c1ccc2nc(N)nc(C(=O)N3Cc4ccccc4C3)c2c1)C(=O)OC(C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 11/20 0.54
HSP90AB1 P08238 3/20 0.47
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
BACE1 P56817 2/20 0.32
BACE2 Q9Y5Z0 2/20 0.32
GRM2 Q14416 1/20 0.32
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
SLC6A4 P31645 1/20 0.31
TLR2 O60603 1/20 0.31
TLR1 Q15399 1/20 0.31
IDO1 P14902 1/20 0.30
TDO2 P48775 1/20 0.30
IDO2 Q6ZQW0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL904078 0.93 HSP90AA1 (0.63) HSP90AA1HSP90AB1TLR2TLR1
SCHEMBL10255660 0.92 HSP90AA1 (0.58) HSP90AA1HSP90AB1TLR2TLR1
SCHEMBL15099529 0.92 HSP90AA1 (0.57) HSP90AA1HSP90AB1ADORA2AADORA1
SCHEMBL10258176 0.90 HSP90AA1 (0.58) HSP90AA1HSP90AB1ADORA2AADORA1
Hydrochloric Acid SCHEMBL15091381 0.89 HSP90AA1 (0.57) HSP90AA1HSP90AB1ADORA2AADORA1
SCHEMBL904245 0.88 HSP90AA1 (0.54) HSP90AA1HSP90AB1ADORA2AADORA1BACE1
SCHEMBL903968 0.86 HSP90AA1 (0.56) HSP90AA1HSP90AB1
SCHEMBL901437 0.85 HSP90AA1 (0.60) HSP90AA1HSP90AB1ADORA2AADORA1
SCHEMBL904242 0.85 HSP90AA1 (0.62) HSP90AA1HSP90AB1ADORA2AADORA1
Hydrochloric Acid SCHEMBL902804 0.85 HSP90AA1 (0.59) HSP90AA1HSP90AB1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
WO-2012041435-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES HSP90B1, HSP90AB1, HSP90AA1 HSP90AA1 3/4885HSP90AB1 2/4885ADORA2A 3896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.